Idiopathic multicentric Castleman disease with marrow fibrosis and extramedullary hematopoiesis

• Published in: European journal of haematology
• Main Authors: Blommers, Marley, Selegean, Sorin, Wood, Richard K, Sarmiento Bustamante, Mateo, Shyamsundar, Saishravan, Wiley, E Ashley, Comeau, Emilie, Shawwa, Allam A, Rose-John, Stefan, Fajgenbaum, David C, Chen, Luke Y C
• Format: Journal Article
• Language: English
• Published: England 29.08.2024
• Subjects: extramedullary hematopoiesis; lymphadenopathy; Castleman disease; IL‐6
• ISSN: 0902-4441; 1600-0609; 1600-0609
• DOI: 10.1111/ejh.14295

Idiopathic multicentric Castleman disease (iMCD) is a rare inflammatory disorder mediated by excessive proinflammatory cytokine signaling, most notably by interleukin 6 (IL-6). IL-6-induced extramedullary hematopoiesis (EMH) has been reported in murine models of iMCD. Herein we present four cases of iMCD with EMH in humans. The index case is a 24-year-old white woman who presented with pancytopenia, hepatosplenomegaly, and diffuse lymphadenopathy (LAD) with EMH in core lymph node biopsies. We then searched ACCELERATE, a Castleman disease (CD) natural history registry, and identified three additional CD cases with EMH reported in biopsies: A 23-year-old Asian man with fatigue, edema, LAD, and splenomegaly; a 20-year-old white man with fever, dyspnea, LAD, and hepatosplenomegaly; and a 50-year-old white man with constitutional symptoms, LAD, and myelodysplastic syndrome in bone marrow with a KRAS mutation. All four patients presented with thrombocytopenia and fever and/or markedly elevated C-reactive protein. Patient 1 had iMCD-NOS (not otherwise specified) with severe thrombocytopenia, reticulin fibrosis in bone marrow, small volume LAD and organomegaly but no anasarca. The other three patients had iMCD-TAFRO (thrombocytopenia, anasarca, reticulin fibrosis, renal dysfunction, organomegaly). Two had mixed CD and two had hypervascular CD in lymph nodes. All four had bone marrow hypercellularity and megakaryocyte hyperplasia and two had reticulin fibrosis. This case series demonstrates that EMH can be seen in CD, particularly in iMCD-TAFRO. Given the similarity of this finding to previous murine models of IL-6-induced marrow and lymph node changes we hypothesize that this is an IL-6-mediated phenomenon.